SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-016651
Filing Date
2021-07-12
Accepted
2021-07-12 17:11:21
Documents
1
Period of Report
2021-07-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2962
  Complete submission text file 0001493152-21-016651.txt   4294
Mailing Address 15150 AVENUE OF SCIENCE SUITE 200 SAN DIEGO CA 92128
Business Address
Townsend John (Reporting) CIK: 0001511906 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40582 | Film No.: 211086146

Mailing Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022
Business Address 5150 EL CAMINO REAL, SUITE A-32 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Issuer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations